Please assess the completion status of the following clinical trial:

Trial Title: Effect of Amygdala Neurofeedback on Depressive Symptoms and Processing Biases

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* clinical diagnosis of major depressive disorder~* right handed~* adult aged 18-55~* currently depressed~Exclusion Criteria:~* clinically significant or unstable cardiovascular, pulmonary, endocrine, neurological, gastrointestinal illness or unstable medical disorder~* met Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) criteria for alcohol and/or substance abuse or substance dependence (other than nicotine) within 12 months prior to screening~* endorse suicidal intent or have made a suicide attempt within the preceding three months~* history of traumatic brain injury~* inability to complete MRI scan due to claustrophobia or general MRI exclusions (e.g., shrapnel inside body)~* current pregnancy or breast feeding~* a primary language other than English~* received psychotropic drugs for at least 3 weeks (8 weeks for fluoxetine) prior to scanning (Effective medications will not be discontinued for the purposes of the study)

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 55 Years
- Healthy Volunteers: f

Study Arms:
- real-time fMRI neurofeedback: Amygdala (Type: EXPERIMENTAL): Amygdala neurofeedback - attempt to upregulate the left amygdala during positive autobiographical memory recall via real time fMRI neurofeedback from the amygdala. Two sessions will be performed one week apart.
- real-time fMRI neurofeedback: HIPS (Type: ACTIVE_COMPARATOR): HIPS neurofeedback - attempt to upregulate the left horizontal segment of the intraparietal sulcus (HIPS), a region not involved in emotional processing, during positive autobiographical memory recall via real time fMRI neurofeedback from the HIPS. Two sessions will be performed one week apart.

Based on this trial design, predict the completion outcome and termination type (if applicable).